3Crowell MD.Pathogenesis of slow transit and pelvic floor dysfunction:from bench to bedside.Rev Gastroenterol Disord,2004,4 Suppl 2:S17-S27.
4Prather CM.Subtypes of constipation:sorting out the confusion.Rev Gastroenterol Disord,2004,4 Suppl 2:S11-S16.
5Heaton KW,Radvan J,Cripps H,Mountford RA,Braddon FE,Hughes AO.Defecation frequency and timing,and stool form in the general population:a prospective study.Gut,1992,33:818-824.
6Thompson WG,Longstreth GF,Drossman DA,Heaton KW,Irvine E J,Muller-Lissner SA.Functional bowel disorders and functional abdominal pain.Gut,1999,45Suppl 2:Ⅱ 43-Ⅱ 47.
5Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders, and functional abdominal pain[ J ] .Gut, 1999,45 ( suppl Ⅱ ): 43-47.
6.中药新药临床研究指导原则[S].[S].中华人民共和国卫生部,1993.57.
7White W B, Johnson M F, Anders R J, et al. Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease[J]. Am Heart J, 2001,142(6):1010
8Thompson W G, Longstreth G F, Drossman D A, et al. Functional bowel disorders and functional abdominal pain[J]. Gut,1999,45(Suppl II):II43
9Arce D A, Ermocilla C A, Costa H. Evaluation of constipation[J]. Am Fam Physician, 2002, 65(11):2283
10Emmanuel AV, Kamm M A. Response to a behavioural treatment, biofeedback, in constipated patients is associated with improved gut transit and autonomic innervation[J]. Gut, 2001,49(2):214
